Real-time enrollment status for this borderline resectable pancreatic adenocarcinoma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 7:53 AM UTC
| NCT Number | NCT05688215 |
| Recruiting Status | Recruiting |
| Condition | Borderline Resectable Pancreatic Adenocarcinoma |
| Phase | PHASE1 |
| Target Enrollment | 56 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Jonsson Comprehensive Cancer Center |
| Last Updated on CT.gov | May 22, 2026 (May 22, 2026) |
As of July 18, 2026: Clinical trial NCT05688215 is currently recruiting participants. This phase1 study for borderline resectable pancreatic adenocarcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Jonsson Comprehensive Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05688215 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05688215 was last updated May 22, 2026 (May 22, 2026). HelloStudys verifies this status automatically.